pharma · Opioid Use Disorder · Opioid Dependence
Indivior Pty
Indivior Pty Ltd
Indivior is a pharma organization headquartered in Richmond, USA. Primary therapeutic focus areas include Opioid Use Disorder, Opioid Dependence, Schizophrenia, Opioid Dependency, Opiate Dependence. NovaPharmaNews links
., Richmond, VA, US HQ
967 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- ., Richmond, VA, US
- Employees
- 967
- Programs
- 39
- Drugs
- 19
- Patents
- 34
buprenorphine and low-dose naloxone
Unknown · small molecule · Pain
buprenorphine and low-dose naloxone for Pain is a Unknown program (small_molecule) at Indivior Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code 07-06-005
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Indivior Pty Ltd
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- Pain
- Status
- completed
- Trials
- 1